Contact
QR code for the current URL

Story Box-ID: 122968

Profos AG Josef-Engert-Str. 11 93053 Regensburg, Germany http://www.profos.de
Contact Ms Dr. Stephanie Steck +49 941 942620
Company logo of Profos AG
Profos AG

Profos introduces EndoGrade™ Ovalbumin

Today Profos AG announced the launch of EndoGrade™ Ovalbumin with highest quality (endotoxin conc. < 1 EU/mg) for in vivo and in vitro immunological studies

(PresseBox) (Regensburg, )
Microbiological contamination is a well recognized problem of research reagents in many applications. Especially elevated endotoxin levels often lead to misinterpretations in cell culture or animal model experiments. Today, Profos AG, Regensburg is pleased to announce the imminent launch of EndoGrade™ Ovalbumin.
With the first of the globally unique EndoGrade™ products – with lowest endotoxin content – Profos sets new quality guidelines for reagents in immunology and cell culture.

The glycoprotein ovalbumin is the main constituent in egg white. Currently ovalbumin is one of the extensively used proteins in animal studies and also an established model allergen for airway hyper-responsiveness (AHR). Using its proprietary technology EndoTrap® Profos AG established an efficient endotoxin removal process to provide ovalbumin with lowest endotoxin content. The product is designed to give researchers the ability to ensure accurate results by avoiding side effects by endotoxin stimulation.

With EndoGrade™ Ovalbumin Profos takes another step to become a global market leader in the field of endotoxin removal systems and high-quality endotoxin-free products. Further products are in development and will expand the growing portfolio continuously.

Profos AG

Profos AG, founded in 2000, employs a total of 58 permanents staff and is certified according to ISO 9001:2000 and ISO13485:2003. Profos’ core competency is to exploit the principles of bacteriophage biology for pharmaceutical, diagnostic and research applications.

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.